Early treatment of Favipiravir in COVID-19 patients without pneumonia: a multicentre, open-labelled, randomized control studyArticle Published on 2022-12-012022-11-15 Journal: Emerging Microbes & Infections [Category] [DOI] 10.1080/22221751.2022.2117092 PMC 바로가기
Status epilepticus during the COVID-19 pandemic in Cologne, Germany: data from a retrospective, multicentre registryArticle Published on 2022-11-012022-11-16 Journal: Journal of Neurology [Category] [DOI] 10.1007/s00415-022-11260-2 PMC 바로가기
Oral saliva swab reverse transcription PCR for Covid-19 in the paediatric populationArticle Published on 2022-11-012022-11-16 Journal: Archives of Disease in Childhood [Category] [DOI] 10.1136/archdischild-2021-323712 PMC 바로가기
Mid-term pulmonary sequelae after hospitalisation for COVID-19: The French SISCOVID cohortResearch article Published on 2022-11-012022-10-05 Journal: Respiratory medicine and research [Category] [DOI] 10.1016/j.resmer.2022.100933 [Article Type] Research article
Severe immunosuppression is related to poorer immunogenicity to SARS-CoV-2 vaccines among people living with HIVArticle Published on 2022-11-012022-11-15 Journal: Clinical microbiology and infection : the official [Category] [DOI] 10.1016/j.cmi.2022.05.018 PMC 바로가기
COVID-19 vaccine-induced antibody and T-cell responses in immunosuppressed patients with inflammatory bowel disease after the third vaccine dose (VIP): a multicentre, prospective, case-control studyArticle Published on 2022-11-012022-11-15 Journal: The Lancet. Gastroenterology & Hepatology [Category] [DOI] 10.1016/S2468-1253(22)00274-6 PMC 바로가기
Cutaneous adverse reactions following SARS-CoV-2 vaccine booster dose: a real-life multicentre experienceArticle Published on 2022-11-012022-11-15 Journal: Journal of the European Academy of Dermatology and [Category] [DOI] 10.1111/jdv.18386 PMC 바로가기
A multinational, phase 2, randomised, adaptive protocol to evaluate immunogenicity and reactogenicity of different COVID-19 vaccines in adults ≥75 already vaccinated against SARS-CoV-2 (EU-COVAT-1-AGED): a trial conducted within the VACCELERATE networkArticle Published on 2022-10-082022-11-15 Journal: Trials [Category] [DOI] 10.1186/s13063-022-06791-y PMC 바로가기
The paradox of pulmonary arterial hypertension in Italy in the COVID-19 era: is risk of disease progression around the corner?Article Published on 2022-10-062022-11-15 Journal: The European Respiratory Journal [Category] [DOI] 10.1183/13993003.02276-2021 PMC 바로가기
Canakinumab in patients with COVID-19 and type 2 diabetes – A multicentre, randomised, double-blind, placebo-controlled trialArticle Published on 2022-09-172022-10-06 Journal: EClinicalMedicine [Category] [DOI] 10.1016/j.eclinm.2022.101649 PMC 바로가기 [Article Type] Article